Quarterly Results

  • Company Name :
Rubicon Research Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 544578
  • NSE Symbol:
  • RUBICON
  • P/E(TTM):
  • 104.37
  • ISIN Demat:
  • INE506V01022
  • Div & Yield%:
  • 0.00
  • EPS(TTM):
  • 9.62
  • Book Value(₹):
  • 76.31
  • Market Cap(₹Cr.):
  • 16,540.93
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars March 2026 ( Cr)December 2025 ( Cr)September 2025 ( Cr)
Gross Sales 389.88 301.71 336.47
Excise Duty 0.00 0.00 0.00
Net Sales 389.88 301.71 336.47
Other Operating Income 0.00 0.00 0.00
Other Income 3.58 4.30 1.51
Total Income 393.46 306.01 337.98
Total Expenditure 283.71 239.46 257.37
PBIDT 109.75 66.55 80.61
Interest 5.40 7.51 9.21
PBDT 104.35 59.04 71.41
Depreciation 10.17 9.51 9.78
Tax 29.15 10.12 19.12
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -4.98 2.23 -3.30
Reported Profit After Tax 70.02 37.18 45.81
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 70.02 37.18 45.81
EPS (Unit Curr.) 4.25 2.28 2.97
EPS (Adj) (Unit Curr.) 4.25 2.28 2.97
Calculated EPS (Unit Curr.) 4.24 2.26 2.97
Calculated EPS (Adj) (Unit Curr.) 4.24 2.26 2.97
Calculated EPS (Ann.) (Unit Curr.) 16.97 9.03 11.87
Calculated EPS (Adj) (Ann.) (Unit Curr.) 16.97 9.03 11.87
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 16.51 16.48 15.44
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 28.15 22.06 23.96
PBDTM(%) 26.76 19.57 21.22
PATM(%) 17.96 12.32 13.61